0000899140-24-000517.txt : 20240502 0000899140-24-000517.hdr.sgml : 20240502 20240502172751 ACCESSION NUMBER: 0000899140-24-000517 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20240422 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUVRETTA CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001569064 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 24909961 BUSINESS ADDRESS: STREET 1: 540 MADISON AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127025204 MAIL ADDRESS: STREET 1: 540 MADISON AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cowen Aaron CENTRAL INDEX KEY: 0001869640 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 24909960 MAIL ADDRESS: STREET 1: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Averill Madison Master Fund, Ltd. CENTRAL INDEX KEY: 0002021243 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 24909959 BUSINESS ADDRESS: STREET 1: C/O SUVRETTA CAPITAL MANAGEMENT, LLC STREET 2: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-702-5205 MAIL ADDRESS: STREET 1: C/O SUVRETTA CAPITAL MANAGEMENT, LLC STREET 2: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Averill Master Fund, Ltd. CENTRAL INDEX KEY: 0001939329 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 24909958 BUSINESS ADDRESS: STREET 1: C/O SUVRETTA CAPITAL MANAGEMENT, LLC STREET 2: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-702-5205 MAIL ADDRESS: STREET 1: C/O SUVRETTA CAPITAL MANAGEMENT, LLC STREET 2: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Benitec Biopharma Inc. CENTRAL INDEX KEY: 0001808898 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 780-0819 MAIL ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 3 1 form3.xml X0206 3 2024-04-22 0 0001808898 Benitec Biopharma Inc. BNTC 0001569064 SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 true 0001869640 Cowen Aaron C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 true 0002021243 Averill Madison Master Fund, Ltd. C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 true 0001939329 Averill Master Fund, Ltd. C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 true Common stock, par value $0.0001 per share 1470179 I I Common stock, par value $0.0001 per share 221111 I I Pre-Funded Warrants 0.0017 2022-09-15 Common Stock 588235 I I Pre-Funded Warrants 0.0001 2023-08-11 Common Stock 4605000 I I Pre-Funded Warrants 0.0001 2024-04-22 Common Stock 1726203 I I Pre-Funded Warrants 0.0001 2023-08-11 Common Stock 576347 I I Pre-Funded Warrants 0.0001 2024-04-22 Common Stock 276353 I I Series 2 Common Warrants 1.9299 2022-12-09 2027-12-09 Common Stock 588236 I I Common Warrants 3.86 2023-08-11 2028-08-11 Common Stock 4605000 I I Common Warrants 3.86 2023-08-11 2028-08-11 Common Stock 576347 I I See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 Exhibit List: ------------- Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signatures By: /s/Andrew Nathanson, Suvretta Capital Management, LLC, General Counsel & Chief Compliance Officer 2024-05-02 EX-99.1 2 s050224a.htm EXPLANATION OF RESPONSES
Exhibit 99.1


Explanation of Responses:

(1)
This Form 3 is filed on behalf of  Averill Master Fund, Ltd., a Cayman Islands exempted company (“Averill Master Fund”), Averill Madison Master Fund, Ltd., a Cayman Islands exempted company (“Averill Madison Master Fund” and, together with the Averill Master Fund, the “Funds”), Suvretta Capital Management, LLC, a Delaware limited liability company (“Suvretta Capital”), and Aaron Cowen (“Mr. Cowen”) (collectively, the “Reporting Persons”).
(2)
Reflects shares of common stock, par value $0.0001 per share (the “Common Stock”), of Benitec Biopharma Inc. (the “Issuer”) directly held by Averill Master Fund.
(3)
Reflects shares of shares of Common Stock of the Issuer directly held by Averill Madison Master Fund.
(4)
Mr. Cowen may be deemed to control Suvretta Capital and therefore may be deemed to beneficially own shares of Common Stock held by the Funds.  Mr. Cowen disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of any indirect pecuniary interest therein.
(5)
The Pre-Funded Warrants reflected herein  are exercisable at any time after their applicable original issuance and expire when exercised in full.
(6)
Reflects warrants directly held by Averill Master Fund acquired as part of the Issuer’s underwritten public offering in  September 2022.
(7)
Reflects warrants directly held by Averill Master Fund acquired as part of the Issuer’s underwritten public offering in August 2023.
(8)
Reflects warrants directly held by Averill Master Fund acquired as part of the Issuer’s private placement in April 2024.
(9)
Reflects warrants directly held by Averill Madison Master Fund acquired as part of the Issuer’s underwritten public offering in August 2023.
(10)
Reflects warrants directly held by Averill Madison Master Fund acquired as part of the Issuer’s private placement in April 2024.
(11)
Mr. Cowen may be deemed to control Suvretta Capital and therefore may be deemed to beneficially own shares of Common Stock underlying the warrants held by the Funds.  Mr. Cowen disclaims beneficial ownership of the shares of Common Stock underlying such warrants reported herein except to the extent of any indirect pecuniary interest therein.
(12)
The exercise of the reported warrants is subject to beneficial ownership limitations on exercise set forth in the applicable warrant; the number of shares underlying such warrants is reported herein without regard to any limitations on exercise contained therein.

EX-99.2 3 s050224b.htm JOINT FILER INFORMATION

Exhibit 99.2



Joint Filer Information


1. Name:
Aaron Cowen
Address:
c/o Suvretta Capital Management, LLC
 
540 Madison Avenue, 7th Floor
 
New York, NY 10022
   
2. Name:
Averill Master Fund, Ltd.
Address:
c/o Suvretta Capital Management, LLC
 
540 Madison Avenue, 7th Floor
 
New York, NY 10022
   
3. Name:
Averill Madison Master Fund, Ltd.
Address:
c/o Suvretta Capital Management, LLC
 
540 Madison Avenue, 7th Floor
 
New York, NY 10022
EX-99.3 4 s050224c.htm JOINT FILERS' SIGNATURES
Exhibit 99.3


Joint Filers’ Signatures
 
AVERILL MASTER FUND, LTD.
  
   
   
By: /s/ Andrew Nathanson
Date:  May 2, 2024
     Name:  Andrew Nathanson
  
     Title:  Authorized Signatory
  
   
   
AVERILL MADISON MASTER FUND, LTD.
  
   
   
By: /s/Andrew Nathanson
Date:  May 2, 2024
     Name:  Andrew Nathanson
  
     Title:  Authorized Signatory
  
   
   
By: /s/  Aaron Cowen
Date:  May 2, 2024
     Name:  Aaron Cowen